For instance, in an IgA-Kappa MM patient, this assay allows a more precise measurement of the monoclonal (IgA-Kappa) and non-monoclonal (IgA-Lambda) immunoglobulins, separately. Here, CD79A is linked to Miyoshi myopathy.